Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for American Healthcare REIT (AHR) over the last 10 years, with Q3 2025 value amounting to $258.5 million.

  • American Healthcare REIT's Capital Expenditures rose 153327.65% to $258.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $370.1 million, marking a year-over-year increase of 32217.75%. This contributed to the annual value of $91.9 million for FY2024, which is 786.74% down from last year.
  • American Healthcare REIT's Capital Expenditures amounted to $258.5 million in Q3 2025, which was up 153327.65% from $60.7 million recorded in Q2 2025.
  • In the past 5 years, American Healthcare REIT's Capital Expenditures ranged from a high of $258.5 million in Q3 2025 and a low of -$1.9 million during Q4 2022
  • In the last 5 years, American Healthcare REIT's Capital Expenditures had a median value of $21.9 million in 2023 and averaged $38.1 million.
  • Data for American Healthcare REIT's Capital Expenditures shows a peak YoY increase of 135662500.0% (in 2022) and a maximum YoY decrease of 84352.94% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows American Healthcare REIT's Capital Expenditures stood at $255000.0 in 2021, then crashed by 843.53% to -$1.9 million in 2022, then surged by 1439.93% to $25.4 million in 2023, then increased by 16.84% to $29.7 million in 2024, then soared by 770.89% to $258.5 million in 2025.
  • Its Capital Expenditures stands at $258.5 million for Q3 2025, versus $60.7 million for Q2 2025 and $21.2 million for Q1 2025.